Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin vs azithromycin for pulmonary function in bronchiectasis
IRCT20100102002954N28Phase 3Completed
- Sponsor
- Shahroud University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levofloxacin and azithromycin in bronchiectasis (2 arms), sponsored by Shahroud University of Medical Sciences. Primary endpoint: Pulmonary function improvement. Started Sep 2022; status: completed.
02
Drugs
levofloxacinazithromycin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on IRCT20100102002954N28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100102002954N28.